Maia Biotechnology Inc.
MAIA
MAIA Biotechnology, Inc. (MAIA, the Company, we, or us) is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. Ateganosine (THIO, 6-thio-dG or 6-thio-2 -deoxyguanosine), our lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$25M
▲ +3.7% YoY
Op. Margin
–
ROIC
-133.23%
▲ +13.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$25M
▼ -20.0% YoY
Net Debt
$0.00
Cash & Equiv.
$0.00
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with MAIA
Held by ETFs
MAIA is in 1 US ETF. The largest of them, with MAIA's weight in each:
Maia Biotechnology (MAIA) in three numbers
Questions about Maia Biotechnology
Is Maia Biotechnology a high-quality business?
Maia Biotechnology scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 3 checks computed from SEC filings. Its best check is share count change at 556.1%. The Quality tab shows every check against its target.
Does Maia Biotechnology (MAIA) pay a dividend?
No. Maia Biotechnology (MAIA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 9 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in MAIA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MAIA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.